Immunome News and Activities
Presence
Immunome is a biotechnology company that develops antibody-based medicines and targeted cancer treatments. Its products and research services support patients, healthcare providers, and biopharmaceutical partners in oncology and infectious disease markets.
Immunome products and services overview:
- Cancer therapies
- Antibody medicines
- Targeted therapeutics
- Drug discovery
- Clinical development
Revenue: ~$20 million
Employees: 300
Headquarters: Bothell, United States (USA)
Immunome is one of the...
Immunome is a company listed under the stock ticker IMNM (US).
Executives
View the org chart displaying its 29 main executives
Most searched biographies at Immunome
- Clay Siegall, Chairman of the Board, President & Chief Executive O...
- Philip Wagenheim, Director
- Isaac Barchas, Lead Independent Director and Director
Popular executive movements at Immunome
- Erik Nelson, Head, Information Technology, has left the company (posted on April 24 2026).
Create your alert
to follow the executive moves at Immunome.
Biotechnology
Immunome has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
- NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
- Rallybio and Avenzo Therapeutics have announced they will merge (posted on June 1 2026)..
Popular contacts in Biotechnology
News
Press releases by Immunome
Social media about Immunome
- Immunome on Wikipedia, Google News & Yahoo Finance
- Immunome on LinkedIn, X (Twitter) & YouTube
